Among the remaining 18 patients in Group B, 9 patients had positive anti-HBs levels at the end of treatment, which remained positive during follow-up, with a majority showing an increasing trend.
← all excerpts
Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation.
1
—
—